SSKN - STRATA Skin Sciences Inc
IEX Last Trade
3.37
-0.210 -6.231%
Share volume: 23,079
Last Updated: Fri 30 Aug 2024 07:40:28 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$3.58
-0.21
-5.87%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-10 | 2022-11-09 | 2023-03-31 | 2023-05-15 | 2023-08-09 | 2023-11-14 | 2024-03-28 | 2024-05-15 | |
| Assets | |||||||||
| Total Assets | 53.587 M | 53.235 M | 52.272 M | 49.123 M | 55.204 M | 47.193 M | 42.016 M | 40.048 M | |
| Current Assets | 18.628 M | 18.753 M | 17.504 M | 14.512 M | 21.245 M | 19.722 M | 15.543 M | 13.239 M | |
| Inventories | 4.907 M | 5.662 M | 5.547 M | 5.695 M | 5.921 M | 6.125 M | 2.673 M | 2.695 M | |
| Other Current Assets | 696.000 K | 621.000 K | 691.000 K | 691.000 K | 528.000 K | 330.000 K | 312.000 K | 343.000 K | |
| Short Term Investments | 696.000 K | 621.000 K | 691.000 K | 691.000 K | 528.000 K | 330.000 K | 312.000 K | 343.000 K | |
| Total Receivables | 2.989 M | 3.655 M | 4.471 M | 3.940 M | 4.401 M | 4.802 M | 4.440 M | 3.630 M | |
| Current Cash | 10.036 M | 7.454 M | 5.434 M | 2.825 M | 9.034 M | 7.131 M | 6.784 M | 5.237 M | |
| Total Non-current Assets | 34.959 M | 34.482 M | 34.768 M | 34.611 M | 33.959 M | 27.471 M | 26.473 M | 26.809 M | |
| Property Plant Equipment | 6.685 M | 6.566 M | 7.498 M | 8.182 M | 8.319 M | 8.256 M | 11.778 M | 11.726 M | |
| Other Assets | 185.000 K | 167.000 K | 98.000 K | 82.000 K | 71.000 K | 71.000 K | 231.000 K | 231.000 K | |
| Intangible Assets | 18.829 M | 18.110 M | 17.394 M | 16.674 M | 15.959 M | 9.623 M | 7.319 M | 6.825 M | |
| Goodwill | 8.803 M | 8.803 M | 8.803 M | 8.803 M | 8.803 M | 8.803 M | 6.519 M | 6.519 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 53.587 M | 53.235 M | 52.272 M | 49.123 M | 55.204 M | 47.193 M | 42.016 M | 40.048 M | |
| Total liabilities | 31.247 M | 31.435 M | 30.441 M | 29.802 M | 38.295 M | 31.000 M | 29.328 M | 30.616 M | |
| Total current liabilities | 14.362 M | 14.158 M | 13.426 M | 13.058 M | 14.120 M | 12.025 M | 12.174 M | 12.588 M | |
| Accounts Payable | 4.241 M | 4.369 M | 3.425 M | 3.099 M | 3.880 M | 3.157 M | 3.343 M | 3.592 M | |
| Other liabilities | 8.935 M | 8.902 M | 8.623 M | 8.432 M | 8.495 M | 3.371 M | 1.687 M | 1.601 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 7.395 M | 7.435 M | 7.476 M | 7.517 M | 14.987 M | 15.016 M | 15.044 M | 15.075 M | |
| Other liabilities | 8.935 M | 8.902 M | 8.623 M | 8.432 M | 8.495 M | 3.371 M | 1.687 M | 1.601 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 22.340 M | 21.800 M | 21.831 M | 19.321 M | 16.909 M | 16.193 M | 12.688 M | 9.432 M | |
| Common stock | 34.723 M | 34.723 M | 34.724 M | 34.862 M | 34.881 M | 34.912 M | 35.026 M | 35.061 M | |
| Retained earnings | -226.073 M | -227.068 M | -227.228 M | -230.063 M | -233.211 M | -234.264 M | -238.058 M | -241.426 M |